for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Arch Biopartners Discloses New Patent Filing For Novel Drug Candidates To Prevent Lung Inflammation

March 24 (Reuters) - Arch Biopartners Inc:

* ARCH BIOPARTNERS DISCLOSES NEW PATENT FILING FOR NOVEL DRUG CANDIDATES TO PREVENT LUNG INFLAMMATION

* ARCH BIOPARTNERS - EVALUATING POSSIBILITIES TO USE METABLOK IN PHASE II TRIAL FOR LUNG INFLAMMATION DUE TO VIRAL PNEUMONIA IN COVID-19 INFECTED PATIENTS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up